Medicines Development For Global Health Limited
09622645
Some Concerns
No risk factors detected.
Details
Compliance
Last accounts
30/06/2025
total exemption full
Next accounts due
31/03/2027
Confirmation statement
Last: 03/06/2025
Due 17/06/2026
Industry
Officers
director · Since 29/03/2018
VP COMMERCIAL OPERATIONS
BRITISH · UNITED KINGDOM · Age 65
Also on 3 other boards
director · Since 04/10/2021
DIRECTOR
BRITISH · UNITED KINGDOM · Age 64
Also on 1 other board
CompanyRankvs 63336+ SIC 86900 peers28
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
—
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
—
Working capital
Current Assets
—
Current Liabilities
—
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 0.70 | +£62k |
| 2022 | 0.50 | — |
| 2021 | 1.00 | — |
| 2020 | 2.03 | — |
| 2019 | 0.89 | — |
Derived from filed accounts. Not audited figures.